Veteran equity strategist and portfolio manager focused on small- and mid-cap growth and value opportunities in North American markets. Scott L. Comeau leads research-driven active equity portfolios with emphasis on fundamental analysis, thematic stock selection and risk-managed position sizing. Prior experience spans sell-side research, institutional portfolio management and public company advisory roles; known for integrating macro insights with bottom-up stock picking. Works with institutional clients on portfolio construction and performance attribution.
Veteran equity strategist and portfolio manager focused on small- and mid-cap growth and value opportunities in North American markets. Scott L. Comeau leads research-driven active equity portfolios with emphasis on fundamental analysis, thematic stock selection and risk-managed position sizing. Prior experience spans sell-side research, institutional portfolio management and public company advisory roles; known for integrating macro insights with bottom-up stock picking. Works with institutional clients on portfolio construction and performance attribution.
Research-driven investor targeting small- and mid-cap North American equities through a blend of fundamental, thematic and macro-informed stock selection. Prefers concentrated, high-conviction positions sized by risk budget and active loss limits; balances growth and value opportunities across sectors. Emphasizes rigorous due diligence, performance attribution and portfolio construction for institutional mandates, pursuing multi-quarter to multi-year horizons while managing downside with disciplined position sizing and liquidity awareness.
Research-driven investor targeting small- and mid-cap North American equities through a blend of fundamental, thematic and macro-informed stock selection. Prefers concentrated, high-conviction positions sized by risk budget and active loss limits; balances growth and value opportunities across sectors. Emphasizes rigorous due diligence, performance attribution and portfolio construction for institutional mandates, pursuing multi-quarter to multi-year horizons while managing downside with disciplined position sizing and liquidity awareness.
| Trades 598 | Longs Won 425/598 71% | Profit Factor 26.14 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $879,165.04 |
| Average Win $170,671.08 | Best Trade (Oct 17) $19.13M | Sharpe Ratio -9.09 |
| Average Loss -$16,041.51 | Worst Trade (Oct 17) -$241,262.24 | Z-Score 8.72 (100%) |
| Commissions $0 | Avg. Trade Length 1y 2m 4w | Expectancy $116,655.57 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.01% |
| Consecutive Losing Trades | 19,231 | 17,308 | 15,385 | 13,462 | 11,538 | 9,615 | 7,692 | 5,769 | 3,846 | 1,923 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 1,043 | $270,277.54 | $358,228.78 | - | $87,951.24 | 32.54% | +0.427% |
ABBV AbbVie Inc. | 5,155 | $817,444.87 | $1.47M | - | $653,895.23 | 79.99% | +0.713% |
ABT Abbott Laboratories | 4,795 | $532,447.24 | $502,899.6 | - | -$29,547.64 | -5.55% | +0.191% |
ACWX ISHARES MSCI ACWI EX U.S. ETF | 9,633 | $728,447 | $714,961.26 | - | -$13,485.74 | -1.85% | -0.563% |
AMZN Amazon.com Inc | 1,263 | $232,224.47 | $315,750 | - | $83,525.53 | 35.97% | -1.868% |
BAI iShares A.I. Innovation and Tech Active ETF | 37,017 | $1.26M | $1.53M | - | $269,091.8 | 21.39% | -4.777% |
BAX Baxter International Inc. | 20,314 | $771,352.72 | $513,537.92 | - | -$257,814.8 | -33.42% | -1.863% |
BINC iShares Flexible Income Active ETF | 7,795 | $408,627.75 | $395,206.5 | - | -$13,421.25 | -3.28% | +0.02% |
BLCR iShares Large Cap Core ACT ETF | 34,325 | $1.47M | $1.68M | - | $206,760.37 | 14.06% | -1.432% |
BND Vanguard Total Bond Market Index Fund | 5,169 | $382,593.53 | $366,068.58 | - | -$16,524.95 | -4.32% | +0.014% |
BX Blackstone Inc. | 2,968 | $443,953.44 | $316,477.84 | - | -$127,475.6 | -28.71% | -2.353% |
CORO Ishares International Country Rotational Active ETF | 32,483 | $1.18M | $1.15M | - | -$26,960.84 | -2.28% | -0.476% |
CVS CVS Health Corporation | 7,472 | $588,343.27 | $690,113.92 | - | $101,770.65 | 17.3% | -0.238% |
DFAC Dimensional U.S. Core Equity 2 ETF | 3.19M | $105.17M | $143.05M | - | $37.89M | 36.03% | -0.907% |
DFCF Dimensional Core Fixed Income ETF | 308,184 | $12.99M | $12.52M | - | -$474,602.57 | -3.65% | 0.0 |
DFEM Dimensional Emerging Markets Core Equity 2 ETF | 364,723 | $10.3M | $13.8M | - | $3.51M | 34.08% | -1.586% |
DFIC Dimensional International Core Equity Market ETF | 1.2M | $33.74M | $45.31M | - | $11.57M | 34.28% | +0.372% |
DFIP Dimensional Inflation-Protected Securities ETF | 138,902 | $5.69M | $5.5M | - | -$192,832.63 | -3.39% | +0.202% |
DFSD Dimensional Short-Duration Fixed Income ETF | 431,344 | $20.41M | $20.2M | - | -$210,980.04 | -1.03% | +0.043% |
DGRO iShares Core Dividend Growth ETF | 5,197 | $309,472.57 | $409,887.39 | - | $100,414.82 | 32.45% | +0.356% |